Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03005080 · ClinicalTrials.gov registry record

Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
51
Enrollment target

NCT03005080: Completed study, sponsored by Mayo Clinic.

NCT03005080 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03005080 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
51 participants
Enrollment target

Study Summary

This study will use a 22 gene pharmacogenomics panel on 30 children with persistent Gastroesophageal Reflux Disease (GERD) who have not responded to therapy.

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2016-12
Est. Completion 2018-10

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03005080

The ClinicalTrials.gov registry entry for NCT03005080 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03005080 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03005080 about?

NCT03005080 is a clinical study titled "Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease". This study will use a 22 gene pharmacogenomics panel on 30 children with persistent Gastroesophageal Reflux Disease (GERD) who have not responded to therapy.

What is the current status of trial NCT03005080?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2016-12. Estimated completion is 2018-10.

Who is sponsoring clinical trial NCT03005080?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.